These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33526861)

  • 1. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4
    Roessner PM; Llaó Cid L; Lupar E; Roider T; Bordas M; Schifflers C; Arseni L; Gaupel AC; Kilpert F; Krötschel M; Arnold SJ; Sellner L; Colomer D; Stilgenbauer S; Dietrich S; Lichter P; Izcue A; Seiffert M
    Leukemia; 2021 Aug; 35(8):2311-2324. PubMed ID: 33526861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EOMES is essential for antitumor activity of CD8
    Llaó-Cid L; Roessner PM; Chapaprieta V; Öztürk S; Roider T; Bordas M; Izcue A; Colomer D; Dietrich S; Stilgenbauer S; Hanna B; Martín-Subero JI; Seiffert M
    Leukemia; 2021 Nov; 35(11):3152-3162. PubMed ID: 33731848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBET-expressing Th1 CD4
    Roessner PM; Hanna BS; Öztürk S; Schulz R; Llaó Cid L; Yazdanparast H; Scheffold A; Colomer D; Stilgenbauer S; Lichter P; Seiffert M
    Br J Haematol; 2020 Apr; 189(1):133-145. PubMed ID: 31724172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4
    Thelen B; Schipperges V; Knörlein P; Hummel JF; Arnold F; Kupferschmid L; Klose CSN; Arnold SJ; Boerries M; Tanriver Y
    Front Immunol; 2023; 14():1058267. PubMed ID: 36756120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human CD4
    Pulvirenti N; Silvetri Y; Clemente F; Bosotti R; Carelli E; Moschetti G; Gruarin P; Vasco C; Crosti MC; Sarnicola ML; Valenti L; Prati D; Abrignani S; Geginat J
    Eur J Immunol; 2024 Apr; 54(4):e2350675. PubMed ID: 38396108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses.
    Toda M; Wang L; Ogura S; Torii M; Kurachi M; Kakimi K; Nishikawa H; Matsushima K; Shiku H; Kuribayashi K; Kato T
    Int J Cancer; 2011 Sep; 129(5):1126-36. PubMed ID: 21710495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.
    Rivas JR; Liu Y; Alhakeem SS; Eckenrode JM; Marti F; Collard JP; Zhang Y; Shaaban KA; Muthusamy N; Hildebrandt GC; Fleischman RA; Chen L; Thorson JS; Leggas M; Bondada S
    Leukemia; 2021 Nov; 35(11):3188-3200. PubMed ID: 33731852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
    Alhakeem SS; McKenna MK; Oben KZ; Noothi SK; Rivas JR; Hildebrandt GC; Fleischman RA; Rangnekar VM; Muthusamy N; Bondada S
    J Immunol; 2018 Jun; 200(12):4180-4189. PubMed ID: 29712773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathways.
    Prince AL; Kraus Z; Carty SA; Ng C; Yin CC; Jordan MS; Schwartzberg PL; Berg LJ
    J Immunol; 2014 Jul; 193(2):688-99. PubMed ID: 24943215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eomes expression reports the progressive differentiation of IFN-γ-producing Th1-like γδ T cells.
    Lino CNR; Barros-Martins J; Oberdörfer L; Walzer T; Prinz I
    Eur J Immunol; 2017 Jun; 47(6):970-981. PubMed ID: 28386934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Eomes in human CD4 T cell differentiation: A question of context.
    Dejean AS; Joulia E; Walzer T
    Eur J Immunol; 2019 Jan; 49(1):38-41. PubMed ID: 30536524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
    Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N
    Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.
    Boncompagni G; Tatangelo V; Lopresti L; Ulivieri C; Capitani N; Tangredi C; Finetti F; Marotta G; Frezzato F; Visentin A; Ciofini S; Gozzetti A; Bocchia M; Calzada-Fraile D; Martin Cofreces NB; Trentin L; Patrussi L; Baldari CT
    Cell Death Dis; 2024 Feb; 15(2):144. PubMed ID: 38360867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R.
    De Simone M; Chirichella M; Emming S; Mazzara S; Ranzani V; Gruarin P; Moschetti G; Pulvirenti N; Maglie S; Vasco C; Crosti MC; Rossetti G; Pagani M; Abrignani S; Monticelli S; Geginat J
    Eur J Immunol; 2021 Dec; 51(12):3243-3246. PubMed ID: 34528258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.
    Jadidi-Niaragh F; Ghalamfarsa G; Memarian A; Asgarian-Omran H; Razavi SM; Sarrafnejad A; Shokri F
    Tumour Biol; 2013 Apr; 34(2):929-40. PubMed ID: 23269607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
    Edwards CL; Engel JA; de Labastida Rivera F; Ng SS; Corvino D; Montes de Oca M; Frame TC; Chauhan SB; Singh SS; Kumar A; Wang Y; Na J; Mukhopadhyay P; Lee JS; Nylen S; Sundar S; Kumar R; Engwerda CR
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eomesodermin-expressing type 1 regulatory (EOMES
    Geginat J; Vasco C; Gruarin P; Bonnal R; Rossetti G; Silvestri Y; Carelli E; Pulvirenti N; Scantamburlo M; Moschetti G; Clemente F; Grassi F; Monticelli S; Pagani M; Abrignani S
    Eur J Immunol; 2023 May; 53(5):e2149775. PubMed ID: 36653901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.